Synthesis, characterization, cytotoxicity of mixed ligand complexes of palladium(II) with dipyrido[3,2- d:2'2,3'2-f]quinoxaline/dipyrido[3,2- a:2'2,3'2- c](6,7,8,9-tetrahydro)phenazine and 4-toluensulfonyl-L-amino acid dianion

European Journal of Medicinal Chemistry

Volumn 87, Issue , 2014, Pages 624-630

  Ma, Lili ^a   Ge, Kun ^a   Zhang, Ran ^a   Fu, Wentao ^a   Li, Shenghui ^a   Wang, Shuxiang ^a   Zhou, Guoqiang ^a   Qin, Xinying ^a   Zhang, Jinchao ^a  

^a HEBEI UNIVERSITY   (China)

Author keywords

4 Toluenesulfonyl L amino acids; Cytotoxicity; Dpq Dpqc; Palladium(II); Synthesis

Indexed keywords

4 TOLUENSULFONYL AMINO ACID DIANION; AMINO ACID; ANION; ANTINEOPLASTIC AGENT; CISPLATIN; CYTOTOXIC AGENT; DIPYRIDO[3,2 D:2',3' F]QUINOXALINE DIPYRIDO[3,2 A:2',3' C ](6,7,8,9 TETRAHYDRO)PHENAZINE; LIGAND; NITROGEN; PALLADIUM COMPLEX; PHENAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED RADIATION; MASS SPECTROMETRY; MCF 7 CELL LINE; MTT ASSAY; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET RADIATION; X RAY DIFFRACTION;

EID: 84907919658     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.10.002     Document Type: Article

References (33)

1. A. García, V. Bocanegra-García, J.P. Palma-Nicol-As, G. Rivera. Recent advances in antitubercular natural products. Eur. J. Med. Chem. 49 (2012) 1e23.
2. K.H. Thompson, C. Orvig. Metal complexes in medicinal chemistry: New vistas and challenge in drug design. Dalton Trans. (2006) 761e764.
3. T.W. Hambley. Developing new metal-based therapeutics: Challenges and opportunities. Dalton Trans. (2007) 4929e4937.
4. Z.J. Guo, P.J. Sadler. Metals in medicine, Angew. Chem. Int. Ed. 38 (1999) 1512e1531.
5. B. Rosenberg, L. Van Camp, J.E. Trosko, V.H. Mansour. Platinum compounds: A new class of potent antitumour agents. Nature 222 (1969) 385e386.
6. N.J. Vogelzang, J.J. Rusthoven, J. Symanowski, C. Denham, E. Kaukel, P. Ruffie, U. Gatzemeier, M. Boyer, S. Emri, C. Manegold, C. Niyikiza, P. Paoletti. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 21 (2003) 2636e2644.
7. I.S. Arany, L. Robert. Cisplatin nephrotoxicity. Semin. Nephrol. 23 (2003) 460e464.
8. S.C. Cascinu, L.D. Ferro, E. Fronzoni, M. Catalano. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: A randomized double-blind placebo-controlled trial, J. Clin. Oncol. 13 (1995) 26e32.
9. M.E. Kartalou, M. John. Mechanisms of resistance to cisplatin. Mutat. Res. Fundam. Mol. Mech. Mutagen 478 (2001) 23e43.
10. P. Mistry, L.R. Kelland, G. Abel, S. Sidhar, K.R. Harrap. The relationships between glutathione, glutathione-S-Transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Briti. J. Cancer 64 (1991) 215e220.
11. F. L-evi, J.L. Misset, S. Brienza, R. Adam, G. Metzger, M. Itzakhi, J.P. Caussanel, F. Kunstlinger, S. Lecouturier, A. Descorps-Decl-ere, A chronopharmacologic phase II clinical trial with 5-fluorouracil. folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer. Cancer 69 (1992) 893e900.
12. P.C.A. Bruijnincx, P.J. Sadler. New trends for metal complexes with anticancer activity. Curr. Opin. Chem. Biol. 12 (2008) 197e206.
13. S. Balasubramanian, L.H. Hurlry, S. Neidle. Targeting G-quadruplexes in gene promoters: A novel anticancer strategy. Nat. Rev. Drug Discov. 10 (2011) 261e275.
14. S. Ray, R. Mohan, J.K. Singh, M.K. Samantaray, M.M. Shaikh, D. Panda, P. Ghosh. Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes. J. Am. Chem. Soc. 129 (2007) 15042e15053.
15. J. Ruiz, J. Lorenzo, C. Vicente, G. L-opez, J. María L-opez-de-Luzuriaga, M. Monge, F.X. Avil-es, D. Bautista, V. Moreno, A. Laguna. New palladium(II) and platinum( II) complexes with 9-Aminoacridine: Structures, luminiscence, theoretical calculations, and antitumor activity. Inorg. Chem. 47 (2008) 6990e7001.
16. E.J. Gao, M.C. Zhu, Y. Huang, L. Liu, H.Y. Liu, F.C. Liu, S. Ma, C.Y. Shi. New pHdependent complexes, from mononuclear Pd(II) monomer to heteronuclear [Pd(II),K(I)] polymer: DNA cleavage and cytotoxicity in vitro. Eur. J. Med.Chem. 45 (2010) 1034e1041.
17. A. Matilla, J.M. Tercero, J. Nicl-os-Guti-errez. cis-Dichloro-palladium(II) complexes with diaminosuccinic acid and its diethyl ester: Synthesis, molecular structure, and preliminary DNA-binding and antitumor studies. J. Inorg. Biochem. 55 (1994) 235e247.
18. D.D. Sun, W.Z. Wang, J.V.V. Mao, W.J. Mei, J. Liu. Imidazo [4,5f] [1,10] phenanthroline derivatives as inhibitor of c-myc gene expression in A549 cells via NF-kappaB pathway. Bioorg. Med. Chem. Lett. 22 (2012) 102e105.
19. F. Huq, H. Tayyem, P. Beale, J.Q. Yu. Studies on the activity of three palladium( II) compounds of the form: Trans-PdL2Cl2 where L2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxy-pyridine. J. Inorg. Biochem. 101 (2007) 30e35.
20. S. Kemp, N.J. Wheate, D.P. Buck, M. Nikac, J.G. Collins, J.R. Aldrich-Wright. The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators. J. Inorg. Biochem. 101 (2007) 1049e1058.
21. K.H. Puthraya, T.S. Srivastava, A.J. Amonkar, M.K. Adwankar, M.P. Chitnis. Some potential anticancer palladium(II) complexes of 2,20-bipyridine and amino acids. J. Inorg. Biochem. 26 (1986) 45e54.
22. R.S. Mital, T.S. Parekh, H.K. Chitnis. Synthesis, characterization, DNA binding, and cytotoxic studies of some mixed-ligand palladium(II) and platinum(II) complexes of a-diimine and amino acids. J. Inorg. Biochem. 41 (1991) 93e103.
23. A.A. El-Sherif. Synthesis and characterization of some potential antitumor palladium(II) complexes of 2-Aminomethylbenzimidazole and amino acids. J. Coord. Chem. 64 (2011) 2035e2055.
24. J.C. Zhang, L.W. Li, L.W. Wang, F.F. Zhang, X.L. Li. Synthesis, characterization and cytotoxicity of mixed-ligand complexes of palladium(II) with aromatic diimine and 4-Toluenesulfonyl-l-Amino acid dianion, Eur. J. Med.Chem. 4 (2010) 5337e5344.
25. J.C. Zhang, L.W. Li, L.L. Ma, F.F. Zhang, Z.L. Zhang, S.X. Wang. Synthesis, characterization and cytotoxicity of mixed-ligand complexes of palladium(II) with 2, 20-biquinoline/1, 4-diaminobutane and 4-Toluenesulfonyl-L-Amino acid dianion. Eur. J. Med. Chem. 46 (2011) 5711e5716.
26. J.C. Zhang, L.L. Ma, H.R. Lu, Y.C. Wang, S.H. Li, S.X. Wang, G.Q. Zhou. Synthesis, characterization and cytotoxicity of platinum(II)/palladium(II) complexes with 1,3-diaminopropane and 4-Toluensulfonyl-L-Amino acid dianion. Eur. J. Med.Chem. 58 (2012) 281e286.
27. J.C. Zhang, L.L. Ma, F.F. Zhang, Z.L. Zhang, L.W. Li, S.X. Wang. Synthesis, characterization, and biological activity of five new mixed-ligand palladium( II) complexes with ethylenediamine and 4-Toluenesulfonyl-L-Amino acid dianion. J. Coord. Chem. 65 (2012) 239e250.
28. J.C. Zhang, L.L. Ma, F.F. Zhang, C. Chen, L.W. Li, S.X. Wang, S.H. Li. Synthesis, characterization, and cytotoxicity of complexes of palladium(II) with 1,4-diaminobutane/1,3-diaminopropane and 4-Toluenesulfonyl-L-Amino acid dianion. J. Coord. Chem. 65 (2012) 3160e3173.
29. J.C. Zhang, F.F. Zhang, L.W. Wang, J.L. Du, S.X. Wang, S.H. Li. Synthesis, characterization, and cytotoxicity of complexes of platinum(II) with 2,20-bipyridine and N-benzoyl-L-Amino acid dianion. J. Coord. Chem. 65 (2012) 2159e2169.
30. S.J. Wang, S.S. Wang, Z.Y. Wang, J.F. Du. Rational design of zinceorganic coordination polymers directed by n-donor co-ligands. Chem. Eur. J. 17 (2012) 8630e8642.
31. M.B. Navarro, H. Adelmo, M. Clara. Palladium polypyridyl complexes: Synthesis, characterization, DNA interaction and biological activity on Leishmania (L.) mexicana. J. Braz. Chem. Soc. 19 (2008) 1355e1360.
32. J.G. Collins, R. Janice, W. Aldrich, G. Ivan, T.W. Hambley, A 1H NMR study of the DNA binding of Ruthenium(II) polypyridyl complexes. Inorg. Chem. 37 (1998) 3133e3141.
33. T. Mosmann. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55e63.